A01K2227/107 - CPC Classification Index

#1

20260013482

2026-01-15

METHOD FOR CONSTRUCTING AN ANIMAL MODEL OF OPEN-ANGLE GLAUCOMA

#2

20240397918

2024-12-05

NON-MEIOTIC ALLELE INTROGRESSION

#3

20230332175

2023-10-19

TRANSGENIC RABBIT WITH COMMON LIGHT CHAIN

#4

20220256822

2022-08-18

GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES

#5

20210185990

2021-06-24

NON-MEIOTIC ALLELE INTROGRESSION

#6

20210161111

2021-06-03

FACTOR VIII OR FACTOR IX GENE KNOCKOUT RABBIT, METHOD FOR PREPARING SAME AND USE THEREOF

#7

20210015439

2021-01-21

Molecular imaging method for evaluating liver regeneration capacity after ALPPS operation

#8

20200362329

2020-11-19

Factor VII Composition Having a Substantially Homogeneous Isoelectric Point

#9

20200344983

2020-11-05

Genetically modified non-human animals and methods for producing heavy chain-only antibodies

#10

20200270596

2020-08-27

Factor VII composition having a substantially homogenous isoelectric point

#11

20200017878

2020-01-16

Non-meiotic allele introgression

#12

20200017877

2020-01-16

Non-meiotic allele introgression

#13

20190335729

2019-11-07

Genetically modified rabbit expressing an exogenous protein in milk

#14

20190261611

2019-08-29

Genetically modified non-human animals and methods for producing heavy chain-only antibodies

#15

20190175894

2019-06-13

Test method

#16

20190113519

2019-04-18

PHARMACOKINETIC ANIMAL MODEL

#17

20190100771

2019-04-04

Transgenic rabbit with common light chain

#18

20190075770

2019-03-14

GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES

#19

20190017021

2019-01-17

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#20

20180244803

2018-08-30

In vivo method for generating diversity in a protein scaffold

#21

20180139938

2018-05-24

TRANSGENIC PRODUCTION OF FC FUSION PROTEINS

#22

20180132458

2018-05-17

TRANSGENIC ANIMAL MODELS FOR CYSTIC FIBROSIS

#23

20170218336

2017-08-03

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#24

20170132952

2017-05-11

Unilateral spinal cord compression

#25

20160304626

2016-10-20

In vivo method for generating diversity in a protein scaffold

#26

20160152965

2016-06-02

Transgenic factor VII having a specific N-glycosylation and substantially homogenous isoelectric point

#27

20150322168

2015-11-12

In vivo method for generating diversity in a protein scaffold

#28

20150125395

2015-05-07

Method for changing condition of an eyelid for evaluation of an eyelid disease involving plugging of meibomian gland orifices and/or telangiectasia by administration of complete freund's adjuvant

#29

20150013025

2015-01-08

TRANSGENIC ANIMALS WITH CUSTOMIZABLE TRAITS

#30

20140093491

2014-04-03

Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

#31

20130203648

2013-08-08

Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbits

#32

20130039901

2013-02-14

Treatment of Pompe's Disease

#33

20120208753

2012-08-16

Composition and Method for the Treatment or Prevention of Spinal Disorders III

#34

20120148543

2012-06-14

SYNTHETIC GRAFT

#35

20110144182

2011-06-16

TREATMENT OF SURGICAL ADHESIONS

#36

20110093963

2011-04-21

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#37

20110059510

2011-03-10

TRANSGENIC RABBITS PRODUCING HUMAN FACTOR VII

#38

20110023140

2011-01-27

RABBIT GENOME EDITING WITH ZINC FINGER NUCLEASES

#39

20100275277

2010-10-28

Infected nail of animal infected with fungus

#40

20100205682

2010-08-12

Humanized immunoglobulin loci

#41

20100092449

2010-04-15

Treatment of Pompe's Disease

#42

20100041743

2010-02-18

TRANSGENIC ANIMAL WITH ENHANCED IMMUNE RESPONSE AND METHOD FOR THE PREPARATION THEREOF

#43

20090311239

2009-12-17

Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

#44

20090239788

2009-09-24

RECOMBINANT OR TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS

#45

20090053210

2009-02-26

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#46

20080299112

2008-12-04

Human Polyclonal Antibodies from Genetically Engineered Animals

#47

20080206223

2008-08-28

Treatment of Pompe's disease

#48

20080184380

2008-07-31

Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals

#49

20070092505

2007-04-26

Production of humanized antibodies in transgenic animals

#50

20070011754

2007-01-11

Lysosomal proteins produced in the milk of transgenic animals

#51

20060259992

2006-11-16

Animal models of long QT syndrome and uses thereof

#52

20060212952

2006-09-21

Methods for cloning mammals using reprogrammed donor chromatin or donor cells

#53

20060117398

2006-06-01

Suppression of endogenous immunoglobulin expression

#54

20060088837

2006-04-27

Expression system for stem-loop rna molecule having rnai effect

#55

20060026696

2006-02-02

Humanized immunoglobulin loci

#56

20050241008

2005-10-27

Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664

#57

20050223416

2005-10-06

C1 inhibitor produced in the milk of transgenic mammals

#58

20050153392

2005-07-14

Transgenesis with humanized immunoglobulin loci

#59

20050066379

2005-03-24

Preparing somatic embryo by utilizing rabbit oocyte